Manufacturer record

Infinitive Pharmaceutical Industries: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

2 batches manufactured by Infinitive Pharmaceutical Industries (Gujarat) were declared Not of Standard Quality between December 2021 and May 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

2 records linked to Infinitive Pharmaceutical Industries in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
2Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Dec 2021 to May 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

2
NSQ batches since 2021
2
Products affected
Dissolution
Most common failure
May 2026
Latest alert

Flagged batches per year

2021 · 12026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Paracetamol Tablets IP 500mg 42675Mfg 2025-04 · Exp 2027-03 DissolutionDissolution RDTL, Bellary, KarnatakaState lab May 2026
RESENT (Ondansetron HCl Tablets I.P. 4 mg) 3233Mfg 2021-06 · Exp 2023-05 DissolutionDissolution CDTL MumbaiCDSCO lab Dec 2021

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.